Regression of liver metastases of occult carcinoid tumor with slow release lanreotide therapy.
about
New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future.Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives.Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives.The Antiproliferative Role of Lanreotide in Controlling Growth of Neuroendocrine Tumors: A Systematic Review.Carcinoid tumor of the kidney: An unusual renal tumor.Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
P2860
Regression of liver metastases of occult carcinoid tumor with slow release lanreotide therapy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Regression of liver metastases ...... ow release lanreotide therapy.
@ast
Regression of liver metastases ...... ow release lanreotide therapy.
@en
type
label
Regression of liver metastases ...... ow release lanreotide therapy.
@ast
Regression of liver metastases ...... ow release lanreotide therapy.
@en
prefLabel
Regression of liver metastases ...... ow release lanreotide therapy.
@ast
Regression of liver metastases ...... ow release lanreotide therapy.
@en
P2093
P2860
P356
P1476
Regression of liver metastases ...... ow release lanreotide therapy.
@en
P2093
Ettore C degli Uberti
Laura Al Jandali Rifa'y
Luigi Cavazzini
Maria Chiara Zatelli
Maria Rosaria Ambrosio
Marta Bondanelli
P2860
P304
P356
10.3748/WJG.V11.I13.2041
P407
P577
2005-04-01T00:00:00Z